Michael Brian Bell - 09 May 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
09 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 16:13:07 UTC
Previous filing
18 Jan 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +39,454 $0.000000 39,454 09 May 2022 COMMON STOCK 39,454 $30.63 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +19,727 $0.000000 19,727 09 May 2022 COMMON STOCK 19,727 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on May 09, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on February 18, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
F2 This represents a restricted stock unit award granted on May 09,2022 that vests over a four-year period. 25% of the shares subject to such award vests on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable for Restricted Stock Units.